332 related articles for article (PubMed ID: 33270528)
1. Longitudinal Changes in Clinical Features, Management, and Outcomes of Idiopathic Pulmonary Fibrosis. A Nationwide Cohort Study.
Moon SW; Kim SY; Chung MP; Yoo H; Jeong SH; Kim DS; Song JW; Lee HL; Choi SM; Kim YW; Kim YH; Park CS; Park SW; Park JS; Jegal Y; Lee J; Uh ST; Kim TH; Lee JH; Kim YH; Shin B; Lee HK; Yang SH; Lee H; Kim SH; Lee EJ; Choi HS; Shin H; Park YB; Shin JW; Park MS
Ann Am Thorac Soc; 2021 May; 18(5):780-787. PubMed ID: 33270528
[No Abstract] [Full Text] [Related]
2. Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis. Data from the IPF-PRO Registry.
Salisbury ML; Conoscenti CS; Culver DA; Yow E; Neely ML; Bender S; Hartmann N; Palmer SM; Leonard TB;
Ann Am Thorac Soc; 2020 Nov; 17(11):1413-1423. PubMed ID: 32574517
[No Abstract] [Full Text] [Related]
3. Comparisons of Prognosis between Surgically and Clinically Diagnosed Idiopathic Pulmonary Fibrosis Using Gap Model: A Korean National Cohort Study.
Lee SH; Kim SY; Kim DS; Kim YW; Chung MP; Uh ST; Park CS; Jeong SH; Park YB; Lee HL; Shin JW; Lee EJ; Lee JH; Jegal Y; Lee HK; Kim YH; Song JW; Park MS
Medicine (Baltimore); 2016 Mar; 95(11):e3105. PubMed ID: 26986154
[TBL] [Abstract][Full Text] [Related]
4. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
Feng H; Zhao Y; Li Z; Kang J
Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
[TBL] [Abstract][Full Text] [Related]
5. Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry.
Jegal Y; Park JS; Kim SY; Yoo H; Jeong SH; Song JW; Lee JH; Lee HL; Choi SM; Kim YW; Kim YH; Choi HS; Lee J; Uh ST; Kim TH; Kim SH; Lee WY; Kim YH; Lee HK; Lee EJ; Heo EY; Yang SH; Kang HK; Chung MP;
Tuberc Respir Dis (Seoul); 2022 Apr; 85(2):185-194. PubMed ID: 34902237
[TBL] [Abstract][Full Text] [Related]
6. The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis.
Lasky JA; Case A; Unterman A; Kreuter M; Scholand MB; Chaudhary S; Lofaro LR; Johnson M; Huang J; Bhorade SM; Kennedy GC
Ann Am Thorac Soc; 2022 Jun; 19(6):916-924. PubMed ID: 34889723
[No Abstract] [Full Text] [Related]
7. Diagnostic Likelihood Thresholds That Define a Working Diagnosis of Idiopathic Pulmonary Fibrosis.
Walsh SLF; Lederer DJ; Ryerson CJ; Kolb M; Maher TM; Nusser R; Poletti V; Richeldi L; Vancheri C; Wilsher ML; Antoniou KM; Behr J; Bendstrup E; Brown KK; Corte TJ; Cottin V; Crestani B; Flaherty KR; Glaspole IN; Grutters J; Inoue Y; Kondoh Y; Kreuter M; Johannson KA; Ley B; Martinez FJ; Molina-Molina M; Morais A; Nunes H; Raghu G; Selman M; Spagnolo P; Taniguchi H; Tomassetti S; Valeyre D; Wijsenbeek M; Wuyts WA; Wells AU
Am J Respir Crit Care Med; 2019 Nov; 200(9):1146-1153. PubMed ID: 31241357
[No Abstract] [Full Text] [Related]
8. Clinical significance of autoantibody positivity in idiopathic pulmonary fibrosis.
Ghang B; Lee J; Chan Kwon O; Ahn SM; Oh JS; Hong S; Kim YG; Yoo B; Jeong WS; Kim J; Lee CK
Respir Med; 2019 Aug; 155():43-48. PubMed ID: 31299466
[TBL] [Abstract][Full Text] [Related]
9. Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis.
Jacob J; Bartholmai BJ; Rajagopalan S; van Moorsel CHM; van Es HW; van Beek FT; Struik MHL; Kokosi M; Egashira R; Brun AL; Nair A; Walsh SLF; Cross G; Barnett J; de Lauretis A; Judge EP; Desai S; Karwoski R; Ourselin S; Renzoni E; Maher TM; Altmann A; Wells AU
Am J Respir Crit Care Med; 2018 Sep; 198(6):767-776. PubMed ID: 29684284
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic Pulmonary Fibrosis Among Young Patients: Challenges in Diagnosis and Management.
Leuschner G; Reiter F; Stocker F; Crispin A; Kneidinger N; Veit T; Klenner F; Ceelen F; Zimmermann G; Leuchte H; Reu S; Dinkel J; Behr J; Neurohr C
Lung; 2018 Aug; 196(4):401-408. PubMed ID: 29761229
[TBL] [Abstract][Full Text] [Related]
11. Right-Angled Traction Bronchiectasis in Differentiating Idiopathic Pulmonary Fibrosis Without Honeycombing From Idiopathic Nonspecific Interstitial Pneumonia.
Kim H; Yoon SH; Lee HJ; Song SG; Koh J; Jeon YK; Chae KJ; Jin GY; Jin KN; Lee KY; Goo JM
Invest Radiol; 2020 Jun; 55(6):387-395. PubMed ID: 32058330
[TBL] [Abstract][Full Text] [Related]
12. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
14. Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis.
de Andrade JA; Neely ML; Hellkamp AS; Culver DA; Kim HJ; Liesching T; Lobo LJ; Ramaswamy M; Safdar Z; Bender S; Conoscenti CS; Leonard TB; Palmer SM; Snyder LD;
Clin Ther; 2023 Apr; 45(4):306-315. PubMed ID: 36997445
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of autoimmune diseases associated with interstitial lung diseases initially presented with idiopathic pulmonary fibrosis].
Chen RX; Liu XN; Shao C; Huang H; Hu K; Xu J; Li X; Zhang ZJ; Xu Z
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Aug; 45(8):775-782. PubMed ID: 35927048
[No Abstract] [Full Text] [Related]
16. Diagnostic and treatment standards in idiopathic pulmonary fibrosis in the era of antifibrotic drugs in Poland: A real-world practice survey.
Majewski S; Lewandowska K; Martusewicz-Boros MM; Piotrowski WJ
Adv Respir Med; 2019; 87(6):221-230. PubMed ID: 31970724
[TBL] [Abstract][Full Text] [Related]
17. [Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].
Doubková M; Uher M; Bartoš V; Šterclová M; Lacina L; Lošťáková V; Binková I; Plačková M; Žurková M; Bittenglová R; Pšikalová J; Šišková L; Lisá P; Petřík F; Polák J; Řihák V; Skřičková J; Vašáková M
Cas Lek Cesk; 2016; 155(4):22-8. PubMed ID: 27481198
[TBL] [Abstract][Full Text] [Related]
18. The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.
Guenther A; Krauss E; Tello S; Wagner J; Paul B; Kuhn S; Maurer O; Heinemann S; Costabel U; Barbero MAN; Müller V; Bonniaud P; Vancheri C; Wells A; Vasakova M; Pesci A; Sofia M; Klepetko W; Seeger W; Drakopanagiotakis F; Crestani B
Respir Res; 2018 Jul; 19(1):141. PubMed ID: 30055613
[TBL] [Abstract][Full Text] [Related]
19. Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis.
Aggarwal R; McBurney C; Schneider F; Yousem SA; Gibson KF; Lindell K; Fuhrman CR; Oddis CV
Rheumatology (Oxford); 2017 Mar; 56(3):384-389. PubMed ID: 28082622
[TBL] [Abstract][Full Text] [Related]
20. Association between weight loss and mortality in idiopathic pulmonary fibrosis.
Kalininskiy A; Rackow AR; Nagel D; Croft D; McGrane-Minton H; Kottmann RM
Respir Res; 2022 Dec; 23(1):377. PubMed ID: 36566185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
